News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
638,215 Results
Type
Article (44441)
Company Profile (184)
Press Release (593590)
Section
Business (179280)
Career Advice (2851)
Deals (33142)
Drug Delivery (108)
Drug Development (74097)
Employer Resources (187)
FDA (15733)
Job Trends (14967)
News (309355)
Policy (29789)
Tag
Academia (2791)
Alliances (45076)
Alzheimer's disease (1355)
Approvals (15693)
Artificial intelligence (180)
Bankruptcy (292)
Best Places to Work (12169)
Biotechnology (121)
Breast cancer (207)
Cancer (1541)
Cardiovascular disease (124)
Career advice (2374)
CAR-T (117)
Cell therapy (334)
Clinical research (59209)
Collaboration (595)
Compensation (313)
COVID-19 (2543)
C-suite (141)
Data (1502)
Diabetes (190)
Diagnostics (6511)
Earnings (68236)
Employer resources (162)
Events (104168)
Executive appointments (505)
FDA (16516)
Funding (522)
Gene therapy (221)
GLP-1 (619)
Government (4191)
Healthcare (19975)
Infectious disease (2640)
Inflammatory bowel disease (124)
Interviews (547)
IPO (16257)
Job creations (3231)
Job search strategy (1988)
Layoffs (418)
Legal (6576)
Lung cancer (228)
Manufacturing (218)
Medical device (13949)
Medtech (13954)
Mergers & acquisitions (17228)
Metabolic disorders (478)
Neuroscience (1734)
NextGen: Class of 2025 (6940)
Non-profit (4876)
Northern California (1909)
Obesity (263)
Opinion (219)
Patents (135)
People (53294)
Phase I (18430)
Phase II (26204)
Phase III (19684)
Pipeline (609)
Postmarket research (2141)
Preclinical (7769)
Radiopharmaceuticals (250)
Rare diseases (300)
Real estate (5393)
Regulatory (20566)
Research institute (2527)
Resumes & cover letters (461)
Southern California (1656)
Startups (3362)
United States (17060)
Vaccines (555)
Weight loss (181)
Date
Today (144)
Last 7 days (411)
Last 30 days (2043)
Last 365 days (36131)
2025 (1822)
2024 (36568)
2023 (41880)
2022 (52615)
2021 (57515)
2020 (56049)
2019 (49348)
2018 (37177)
2017 (32871)
2016 (31455)
2015 (36714)
2014 (26161)
2013 (20854)
2012 (22629)
2011 (23507)
2010 (21055)
Location
Africa (830)
Arizona (154)
Asia (37554)
Australia (6670)
California (4307)
Canada (1562)
China (363)
Colorado (194)
Connecticut (217)
Europe (86277)
Florida (615)
Georgia (156)
Illinois (444)
Indiana (250)
Maryland (689)
Massachusetts (3401)
Michigan (202)
Minnesota (334)
New Jersey (1204)
New York (1220)
North Carolina (852)
Northern California (1909)
Ohio (157)
Pennsylvania (1012)
South America (1161)
Southern California (1656)
Texas (629)
Utah (128)
Washington State (436)
638,215 Results for "ab science".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AB Science: Revenues for the first half of 2024 and update on AB Science’s activities
October 10, 2024
·
21 min read
Press Releases
AB Science provides a summary of the webcast held on December 16, 2024
December 17, 2024
·
7 min read
AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development
AB Science SA is providing a summary of the live webcast held on March 4, 2024, giving an update on AB Science development.
March 7, 2024
·
11 min read
Business
AB Science reports its revenues for the year 2023 and provides an update on its activities
AB Science SA reports its revenues for the year 2023 and provides an update on its activities.
May 15, 2024
·
23 min read
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
AB Science SA (Euronext - FR0010557264 - AB) today announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a trending toward a negative opinion on the application for conditional marketing authorisation of masitinib in the treatment of amyotrophic lateral sclerosis (ALS), following an oral explanation held at the 28 May meeting of the CHMP.
May 29, 2024
·
3 min read
AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036
AB Science SA (Euronext - FR0010557264 - AB) today announced that the European patent office has issued a Grant Decision for a patent relating to methods of treating severe mastocytosis with its lead compound masitinib (patent EP 3359195A1).
May 13, 2024
·
5 min read
Business
AB Science announces a slight delay in the publication of its 2023 annual financial report
AB Science SA announced that it has postponed the publication of its 2023 annual financial report, initially scheduled for 30 April 2024, to give the auditors time to complete their audit work.
April 30, 2024
·
2 min read
Press Releases
AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET
December 11, 2024
·
2 min read
Drug Development
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
October 17, 2024
·
4 min read
AB Science is providing a summary of the live webcast held on May 30, 2024, giving an update on the application for conditional marketing authorization of masitinib in ALS
AB Science SA is providing a summary of the live webcast held on May 30, 2024, giving an update on the application for conditional marketing authorization of masitinib in the treatment of amyotrophic lateral sclerosis.
May 31, 2024
·
5 min read
1 of 63,822
Next
